Pelacarsen Heart Drug Fails Key Trial Despite Lowering Lp(a)November 7, 2026 Health 3 Views An experimental drug designed to lower lipoprotein(a) and prevent heart attacks failed to reduce cardiovascular events in a major study, researchers reported Saturday.
